CHF 17454
Alternative Names: JL 17454; LirexaprideLatest Information Update: 29 May 2001
At a glance
- Originator Chiesi; Logeais
- Developer Logeais
- Class Benzamides; Gastrokinetics
- Mechanism of Action Dopamine D2 receptor agonists; Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Irritable bowel syndrome
Most Recent Events
- 29 May 2001 Discontinued-II for Irritable bowel syndrome in France (Unknown route)
- 27 Nov 2000 Profile reviewed but no significant changes made
- 05 Sep 2000 JL 17454 is now called CHF 17454